These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9112451)

  • 21. Prostate cancer patient subsets showing improved bNED control with adjuvant androgen deprivation.
    Anderson PR; Hanlon AL; Movsas B; Hanks GE
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1025-30. PubMed ID: 9392540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
    Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
    Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer.
    Pollack A; Zagars GK; Smith LG; Lee JJ; von Eschenbach AC; Antolak JA; Starkschall G; Rosen I
    J Clin Oncol; 2000 Dec; 18(23):3904-11. PubMed ID: 11099319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.
    Zelefsky MJ; Leibel SA; Gaudin PB; Kutcher GJ; Fleshner NE; Venkatramen ES; Reuter VE; Fair WR; Ling CC; Fuks Z
    Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):491-500. PubMed ID: 9635694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate.
    Schultheiss TE; Hanks GE; Hunt MA; Lee WR
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):643-9. PubMed ID: 7790250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns and fate of PSA bouncing following 3D-CRT.
    Hanlon AL; Pinover WH; Horwitz EM; Hanks GE
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):845-9. PubMed ID: 11429210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer.
    Valicenti RK; Gomella LG; Ismail M; Mulholland SG; Petersen RO; Corn BW
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):501-6. PubMed ID: 9806507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
    Wong WW; Schild SE; Vora SA; Halyard MY
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):24-9. PubMed ID: 15337536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose selection for prostate cancer patients based on dose comparison and dose response studies.
    Hanks GE; Hanlon AL; Pinover WH; Horwitz EM; Price RA; Schultheiss T
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):823-32. PubMed ID: 10705002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques.
    Horwitz EM; Hanlon AL; Pinover WH; Anderson PR; Hanks GE
    Cancer; 2001 Sep; 92(5):1281-7. PubMed ID: 11571744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis.
    Livsey JE; Cowan RA; Wylie JP; Swindell R; Read G; Khoo VS; Logue JP
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1254-9. PubMed ID: 14630259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose (66 Gy).
    Goldner G; Wachter S; Wachter-Gerstner N; Dieckmann K; Pötter R
    Strahlenther Onkol; 2006 Sep; 182(9):537-42. PubMed ID: 16944376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial.
    Pollack A; Zagars GK; Antolak JA; Kuban DA; Rosen II
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):677-85. PubMed ID: 12377318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect.
    Lee WR; Hanks GE; Hanlon AL; Schultheiss TE; Hunt MA
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):251-7. PubMed ID: 8635930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma.
    Zelefsky MJ; Leibel SA; Kutcher GJ; Kelson S; Ling CC; Fuks Z
    Cancer J Sci Am; 1995; 1(2):142-50. PubMed ID: 9166467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms.
    Boersma LJ; van den Brink M; Bruce AM; Shouman T; Gras L; te Velde A; Lebesque JV
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):83-92. PubMed ID: 9588921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moderate dose escalation in three-dimensional conformal localized prostate cancer radiotherapy: single-institutional experience in 398 patients comparing 66 Gy versus 70 Gy versus 74 Gy.
    Goldner G; Dimopoulos J; Kirisits C; Pötter R
    Strahlenther Onkol; 2009 Jul; 185(7):438-45. PubMed ID: 19714305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D conformal radiation therapy (3DCRT) for high grade prostate cancer: a multi-institutional review.
    Fiveash JB; Hanks G; Roach M; Wang S; Vigneault E; McLaughlin PW; Sandler HM
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):335-42. PubMed ID: 10802357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there a subset of patients with PSA > or = 20 ng/ml who do well after conformal beam radiotherapy?
    Algan O; Pinover WH; Hanlon AL; Al-Saleem TI; Hanks GE
    Radiat Oncol Investig; 1999; 7(2):106-10. PubMed ID: 10333251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.